In addition to leveraging a pipeline of complex generics across its markets while focusing on OTC, Dr. Reddy's chairman K Satish Reddy said the branded generics would be one of the ways the company drives growth in the coming years.
Reuters is reporting that the FDA’s Arthritis Advisory Board has unanimously recommended Amgen’s biosimilar of AbbVie’s Humira, ABP 501. The panel said that the drug was similar in safety and effectiveness to Humira for rheumatoid arthritis and plaque psoriasis, and it recommended that the biosimilar should also be approved for Crohn’s disease in adults and ulcerative colitis. (Reuters)
The move is aimed at Nichi-Iko becoming one of the top 10 global generics leaders, and the companies said acquiring Sagent will boost Nichi-Iko’s ability to commercialize its biosimilar pipeline and increase its presence in injectables.
NACDS and NCPA urged the Senate committee to adopt the House’s position in its version of the National Defense Authorization Act , which does not include provisions that would increase TRICARE copays, arguing that higher copays can have detrimental effects on patient health and federal spending.
Toohey is the former president and CEO of the Semiconductor Industry Association, where he oversaw that industry’s federal advocacy, international trade and technology programs, as well as a veteran of PhRMA’s advocacy team.
Headquartered in New York, Snow Phipps has overseen the deployment of over $1.7 billion of private equity capital and co-investments in 17 platform investments and over 25 add-on acquisitions since inception.
Modern Healthcare is reporting on the recently handed down Supreme Court decision in Cuozzo Speed Technologies v. Lee, which might make it easier for generic drug makers to manufacture generics, but could also make it difficult for companies to protect their patents. The decision allows the Patent and Trademark Office's board for patent trial and appeal to use a broad standard when interpreting patent claims. The Generic Pharmaceutical Association Monday called the decision "one that promotes a competitive, affordable prescription drug market for consumers." (Modern Healthcare)
The pilot program, which in effect would allow the DoD to access lower pricing for prescriptions dispensed at community pharmacies, is included in the version of the NDAA passed by the House on May 18, but not in the version passed by the Senate June 14.